MedPath

Endometrial Biopsy Protocol for In Vitro Fertilization (IVF)

Not Applicable
Conditions
Infertility
Recurrent Implantation Failure
Registration Number
NCT01278706
Lead Sponsor
Kaplan Medical Center
Brief Summary

Endometrial biopsy has been shown to improve IVF pregnancy and live birth rates. The optimal time of performing the biopsy is yet to be established.

In this study, the investigators will compare different temporal timing of the biopsies with regards to the menstrual cycle and their affect on the success rates of the treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • normal menstrual cycle
  • between 1-6 previous failed IVF cycles
  • normal hormonal profile
Exclusion Criteria
  • intrauterine procedure in last 3 months
  • hydrosalpinx
  • intrauterine lesion /malformation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
pregnancy rates2 years
Secondary Outcome Measures
NameTimeMethod
live birth rates3 years

Trial Locations

Locations (2)

Kaplan Medical Center, IVF Unit

🇮🇱

Rehovot, Israel

Weizmann Institute of Science

🇮🇱

Rehovot, Israel

Kaplan Medical Center, IVF Unit
🇮🇱Rehovot, Israel
Levin
Contact
+972-8-9441623
Amihai Barash, M/D/
Principal Investigator
Dan Levin, M.D.
Sub Investigator
Yuval Or, M.D.
Sub Investigator
Irit Granot, Ph.D.
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.